Accolade Total Current Liabilities from 2010 to 2024
| ACCD Stock | USD 3.22 0.14 4.17% |
Total Current Liabilities | First Reported 2019-02-28 | Previous Quarter 98.4 M | Current Value 101 M | Quarterly Volatility 44.7 M |
Check Accolade financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accolade's main balance sheet or income statement drivers, such as Tax Provision of 1.3 M, Net Interest Income of 6.2 M or Interest Income of 218 K, as well as many indicators such as Price To Sales Ratio of 1.89, Dividend Yield of 0.0 or PTB Ratio of 1.81. Accolade financial statements analysis is a perfect complement when working with Accolade Valuation or Volatility modules.
Accolade | Total Current Liabilities |
Latest Accolade's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Accolade over the last few years. Total Current Liabilities is an item on Accolade balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Accolade are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Accolade's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Accolade's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Accolade Total Current Liabilities Regression Statistics
| Arithmetic Mean | 65,195,135 | |
| Geometric Mean | 59,484,076 | |
| Coefficient Of Variation | 46.02 | |
| Mean Deviation | 26,415,362 | |
| Median | 41,497,000 | |
| Standard Deviation | 30,003,013 | |
| Sample Variance | 900.2T | |
| Range | 77.9M | |
| R-Value | 0.87 | |
| Mean Square Error | 243T | |
| R-Squared | 0.75 | |
| Significance | 0.00003 | |
| Slope | 5,807,640 | |
| Total Sum of Squares | 12602.5T |
Accolade Total Current Liabilities History
About Accolade Financial Statements
Accolade stakeholders use historical fundamental indicators, such as Accolade's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Accolade investors may analyze each financial statement separately, they are all interrelated. For example, changes in Accolade's assets and liabilities are reflected in the revenues and expenses on Accolade's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Accolade. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 107.8 M | 92.1 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft |
Check out the analysis of Accolade Correlation against competitors. For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.02) | Revenue Per Share 5.706 | Quarterly Revenue Growth 0.098 | Return On Assets (0.07) | Return On Equity (0.19) |
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.